Heart disease detection device developer Heart Test Labs raised $12 million in a private placement of common stock to support the international launch of its MyoVista product in the 1st quarter. The round was significantly over-subscribed, Heart Test Labs said, and “provides HTL with a strong financial base entering into 2017.” The company said it […]